{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:28:00Z","timestamp":1777858080395,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T00:00:00Z","timestamp":1320192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:p>GSK372475 is a triple reuptake inhibitor with approximately equipotent inhibition of serotonin, norepinephrine, and dopamine transporters. Two randomized, placebo- and active-controlled, double-blind studies examined the efficacy and safety of GSK372475 in outpatients (aged 18\u201364 years) with a diagnosis of major depressive episode associated with major depressive disorder (MDD). Patients were randomized 1:1:1 to placebo, GSK372475 (1\u20132 mg\/d), or active control (Study 1: venlafaxine XR 150\u2013225 mg\/d; Study 2: paroxetine 20\u201330 mg\/d). GSK372475 did not significantly differ from placebo on any of the key efficacy endpoints (six-item Bech scale, IDS-Clinician Rated, MADRS) in either study. Both active controls demonstrated significant antidepressant activity compared with placebo on both primary and secondary endpoints. The most common adverse effects (AEs) with GSK372475 were dry mouth, headache, insomnia, and nausea. AEs were more frequent for GSK372475 versus placebo for sleep, anxiety-related, gastrointestinal, and tachycardia events. Increases in mean change from baseline in heart rate and sitting blood pressure were greater for GSK372475 than observed for either placebo or active control groups. Completion rates were lower for GSK372475 (49%, 58%) compared with placebo (67%, 74%), venlafaxine XR (63%), or paroxetine (77%). GSK372475 was neither efficacious nor well tolerated in patients with MDD in two 10-week studies.<\/jats:p>","DOI":"10.1177\/0269881111424931","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T20:50:59Z","timestamp":1320267059000},"page":"653-662","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials"],"prefix":"10.1177","volume":"26","author":[{"given":"Susan","family":"Learned","sequence":"first","affiliation":[{"name":"Neurosciences Discovery Medicine, Research Triangle Park, NC, USA and Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Graff","sequence":"additional","affiliation":[{"name":"Neurosciences Discovery Medicine, Research Triangle Park, NC, USA and Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraja","family":"Roychowdhury","sequence":"additional","affiliation":[{"name":"Neurosciences Medicines Development Center, Research Triangle Park, NC, USA and Harlow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Moate","sequence":"additional","affiliation":[{"name":"Discovery Biometrics, GlaxoSmithKline, Harlow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K Ranga","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Duke University, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Archer","sequence":"additional","affiliation":[{"name":"Neurosciences Discovery Medicine, Research Triangle Park, NC, USA and Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack G","family":"Modell","sequence":"additional","affiliation":[{"name":"Neurosciences Medicines Development Center, Research Triangle Park, NC, USA and Harlow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Alexander","sequence":"additional","affiliation":[{"name":"Neurosciences Discovery Medicine, Research Triangle Park, NC, USA and Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Zamuner","sequence":"additional","affiliation":[{"name":"Neurosciences Discovery Medicine, Research Triangle Park, NC, USA and Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Lavergne","sequence":"additional","affiliation":[{"name":"Neurosciences Medicines Development Center, Research Triangle Park, NC, USA and Harlow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Evoniuk","sequence":"additional","affiliation":[{"name":"Neurosciences Medicines Development Center, Research Triangle Park, NC, USA and Harlow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliangelo","family":"Ratti","sequence":"additional","affiliation":[{"name":"Neurosciences Discovery Medicine, Research Triangle Park, NC, USA and Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2011,11,2]]},"reference":[{"key":"bibr1-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004269560"},{"key":"bibr2-0269881111424931","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0401"},{"key":"bibr3-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00566-5"},{"key":"bibr4-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1023\/B:QURE.0000037502.64077.4d"},{"key":"bibr5-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"bibr6-0269881111424931","first-page":"178","volume":"25","author":"Hooper CC","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"bibr7-0269881111424931","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0602"},{"key":"bibr8-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1080\/00926230500232909"},{"key":"bibr9-0269881111424931","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0302"},{"key":"bibr10-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01834-6"},{"key":"bibr11-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.5.826"},{"key":"bibr12-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"bibr13-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-006-9012-5"},{"key":"bibr14-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(86)90060-0"},{"issue":"5","key":"bibr15-0269881111424931","first-page":"A305","volume":"62","author":"Seibyl JP","year":"2004","journal-title":"Neurology"},{"key":"bibr16-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59259-852-6_9"},{"key":"bibr17-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2006.00123.x"},{"key":"bibr18-0269881111424931","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v06n0403"},{"key":"bibr19-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(02)00099-8"},{"key":"bibr20-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-4-24"},{"key":"bibr21-0269881111424931","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.06.027"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881111424931","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0269881111424931","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881111424931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:07:08Z","timestamp":1777507628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881111424931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,2]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1177\/0269881111424931"],"URL":"https:\/\/doi.org\/10.1177\/0269881111424931","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,2]]}}}